Skip to main content
SpringerLink
Log in

Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Purpose

It has been reported that elevation of asymmetric dimethylarginine (ADMA) concentration is involved in atrial fibrillation (AF) process. The purpose of this study was to determine whether ADMA concentration is related to recurrences of AF after catheter ablation.

Methods

A total of one hundred and thirty-eight patients with persistent AF (49.91 ± 7.23 years), but without known heart disease, who underwent successful mapping and catheter ablation were included. Serum ADMA levels were measured 1 day before the catheter ablation.

Results

After a mean follow-up period of 285 days (range, 98–651 days), 80 (58%) patients underwent the AF recurrence. Comparing with no AF recurrence group, the serum ADMA concentration, left atrial diameter, and persistent duration of AF in patients with AF recurrence group were significantly increased. Left atrial diameter, persistent duration of AF, and the number of non-pulmonary vein ectopy ablation were increased when serum ADMA concentration was elevated. In addition, AF recurrences were significantly increased when serum ADMA concentration was elevated. A multivariable Cox regression analysis demonstrated that the elevated ADMA concentration [hazard ration (95% CI), 4.59 (1.81–11.62); P = 0.001], the left atrial diameter [1.35 (1.18–1.55), P < 0.001], and the number of non-pulmonary vein ectopy ablation [1.94 (1.18–3.18), P = 0.009] were independent factors associated with the AF recurrence after catheter ablation.

Conclusions

This study demonstrated that (1) serum ADMA concentrations were associated with non-PV ectopies and (2) increased serum ADMA concentrations were associated with higher rate of AF recurrence after catheter ablation in patients with persistent AF, supporting our hypothesis that ADMA might participate in the process of atrial remodeling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Calkins, H., Brugada, J., Packer, D. L., Cappato, R., Chen, S. A., Crijns, H. J., et al. (2007). HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. Heart Rhythm, 4, 816–861.

    Article  PubMed  Google Scholar 

  2. Weerasooriya, R., Khairy, P., Litalien, J., Macle, L., Hocini, M., Sacher, F., et al. (2011). Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? Journal of the American College of Cardiology, 57(2), 160–166.

    Article  PubMed  Google Scholar 

  3. Allessie, M., Ausma, J., & Schotten, U. (2002). Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovascular Research, 54(2), 230–246.

    Article  PubMed  CAS  Google Scholar 

  4. Frustaci, A., Chimenti, C., Bellocci, F., Morgante, E., Russo, M. A., & Maseri, A. (1997). Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation, 96, 1180–1184.

    PubMed  CAS  Google Scholar 

  5. Liu, H., Xiufen, Qu, Liang, Z., Chen, W., Xia, W., & Song, Y. (2008). Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs. Biochemical and Biophysical Research Communications, 377, 884–888.

    Article  PubMed  CAS  Google Scholar 

  6. Xia, W., Qu, X., Yu, Y., Zhang, X., Feng, W., & Song, Y. (2008). Asymmetric dimethylarginine concentration and early recurrence of atrial fibrillation after electrical cardioversion. Pacing and Clinical Electrophysiology, 31, 1036–1040.

    Article  PubMed  Google Scholar 

  7. Maldonado, G., & Greenland, S. (1993). Simulation study of confounder-selection strategies. American Journal of Epidemiology, 138(11), 923–936.

    PubMed  CAS  Google Scholar 

  8. Vallance, P., Leone, A., Calver, A., Collier, J., & Moncada, S. (1992). Accumulation of an endogenous inhibitor of NO synthesis in chronic renal failure. Lancet, 339, 572–575.

    Article  PubMed  CAS  Google Scholar 

  9. De Gennaro Colonna, V., Bianchi, M., Pascale, V., Ferrario, P., Morelli, F., Pascale, W., et al. (2009). Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule. Medical Science Monitor, 15(4), RA91–RA101.

    PubMed  Google Scholar 

  10. Cengel, A., Sahinarslan, A., Biberoğlu, G., Hasanoğlu, A., Tavil, Y., Tulmaç, M., et al. (2008). Asymmetrical dimethylarginine level in atrial fibrillation. Acta Cardiologica, 63(1), 33–37.

    Article  PubMed  Google Scholar 

  11. Lehto, M., Jurkko, R., Parikka, H., Mäntynen, V., Väänänen, H., Montonen, J., et al. (2009). Reversal of atrial remodeling after cardioversion of persistent atrial fibrillation measured with magnetocardiography. Pacing and Clinical Electrophysiology, 32(2), 217–223.

    Article  PubMed  Google Scholar 

  12. Novo, G., Guttilla, D., Fazio, G., Cooper, D., & Novo, S. (2009). The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS. British Journal of Clinical Pharmacology, 66(3), 345–351.

    Article  Google Scholar 

  13. Li, J., Solus, J., Chen, Q., Rho, Y. H., Milne, G., Stein, C. M., et al. (2010). Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm, 7(4), 438–444.

    Article  PubMed  Google Scholar 

  14. Van Wagoner, D. R. (2008). Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. Journal of Cardiovascular Pharmacology, 52(4), 306–313.

    Article  PubMed  Google Scholar 

  15. Van Gelder, I. C., Crijns, H. J., Van Gilst, W. H., Verwer, R., & Lie, K. I. (1991). Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. The American Journal of Cardiology, 68(1), 41–46.

    Article  PubMed  Google Scholar 

  16. Berruezo, A., Tamborero, D., Mont, L., Benito, B., Tolosana, J. M., Sitges, M., et al. (2007). Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. European Heart Journal, 28(7), 836–841.

    Article  PubMed  Google Scholar 

  17. Skalidis, E. I., Zacharis, E. A., Tsetis, D. K., Pagonidis, K., Chlouverakis, G., Yarmenitis, S., et al. (2007). Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm. The American Journal of Cardiology, 1, 99(9), 1258–1262.

    Article  Google Scholar 

  18. Aldhoon, B., Melenovský, V., Peichl, P., & Kautzner, J. (2010). New insights into mechanisms of atrial fibrillation. Physiological Research, 59(1), 1–12.

    PubMed  CAS  Google Scholar 

  19. Kourliouros, A., Savelieva, I., Kiotsekoglou, A., Jahangiri, M., & Camm, J. (2009). Current concepts in the pathogenesis of atrial fibrillation. American Heart Journal, 157(2), 243–252.

    Article  PubMed  Google Scholar 

  20. Yamada, T., Murakami, Y., Okada, T., Yoshida, N., Toyama, J., Yoshida, Y., et al. (2007). Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation. Europace, 9, 770–774.

    Article  PubMed  Google Scholar 

  21. Kallergis, E. M., Manios, E. G., Kanoupakis, E. M., Mavrakis, H. E., Kolyvaki, S. G., Lyrarakis, G. M., et al. (2008). The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation. Heart, 94(2), 133–134.

    Article  Google Scholar 

  22. Trocha, M., Szuba, A., Merwid-Lad, A., & Sozański, T. (2010). Effect of selected drugs on plasma asymmetric dimethylarginine (ADMA) levels. Die Pharmazie, 65(8), 562–571.

    PubMed  CAS  Google Scholar 

  23. Schneider, M. P., Hua, T. A., Böhm, M., Wachtell, K., Kjeldsen, S. E., & Schmieder, R. E. (2010). Prevention of atrial fibrillation by renin-angiotensin system inhibition a meta-analysis. Journal of the American College of Cardiology, 55(21), 2299–2307.

    Article  PubMed  Google Scholar 

  24. Xia, W., Yin, Z., Li, J., Song, Y., & Qu, X. (2009). Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion. Pacing and Clinical Electrophysiology, 32(12), 1562–1566.

    Article  PubMed  Google Scholar 

  25. Lai, J., Zhou, D., Xia, S., Shang, Y., Want, L., Zheng, L., et al. (2009). Reduced testosterone levels in males with lone atrial fibrillation. Clinical Cardiology, 32(1), 43–46.

    Article  PubMed  Google Scholar 

  26. Korantzopoulos, P., Kolettis, T. M., Kountouris, E., Dimitroula, V., Karanikis, P., Pappa, E., et al. (2005). Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. International Journal of Cardiology, 10, 102(2), 321–326.

    Article  Google Scholar 

  27. Kubes, P., & SuzukiM, G. D. N. (1991). Nitric oxide: an endogenous modulator of leukocyte adhesion. Proceedings of the National Academy of Sciences, 88, 4651–4655.

    Article  CAS  Google Scholar 

  28. Sarkar, R., Meinberg, E. G., Stanley, J. C., Gordon, D., & Webb, R. C. (1996). Nitric oxide reversibly inhibits themigration of cultured vascular smooth muscle cells. Circulation Research, 78, 225–230.

    PubMed  CAS  Google Scholar 

  29. Feng, Q., Song, W., Lu, X., Hamilton, J. A., Lei, M., Peng, T., et al. (2002). Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation, 106, 873–879.

    Article  PubMed  CAS  Google Scholar 

  30. Van Wagoner, D. R. (2003). Electrophysiological remodeling in human atrial fibrillation. Pacing and Clinical Electrophysiology, 26, 1572–1575.

    Article  PubMed  Google Scholar 

  31. Cooke, J. P. (2004). Asymmetrical dimethylarginine: the uber marker? Circulation, 109(15), 1813–1818.

    Article  PubMed  Google Scholar 

  32. Suda, O., Tsutsui, M., Morishita, T., Tasaki, H., Ueno, S., Nakata, S., et al. (2004). Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 1682–1688.

    Article  PubMed  CAS  Google Scholar 

  33. Natale, A., Pisanó, E., Beheiry, S., Richey, M., Leonelli, F., Fanelli, R., et al. (2000). Ablation of right and left atrial premature beats following cardioversion in patients with chronic atrial fibrillation refractory to antiarrhythmic drugs. The American Journal of Cardiology, 1,85(11), 1372–1375.

    Article  Google Scholar 

  34. Schmitt, C., Ndrepepa, G., Weber, S., Schmieder, S., Weyerbrock, S., Schneider, M., et al. (2002). Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation. The American Journal of Cardiology, 15,89(12), 1381–1387.

    Article  Google Scholar 

  35. Lin, W. S., Tai, C. T., Hsieh, M. H., Tsai, C. F., Lin, Y. K., Tsao, H. M., et al. (2003). Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation, 1,107(25), 3176–3183.

    Article  Google Scholar 

  36. Stühlinger, M. (2007). Asymmetric dimethylarginine (ADMA): a novel cardiovascular risk factor? Wiener Medizinische Wochenschrift, 157(3–4), 57–60.

    Article  PubMed  Google Scholar 

  37. Szuba, A., & Podgorski, M. (2006). Asymmetric dimethylarginine (ADMA) a novel cardiovascular risk factor—evidence from epidemiological and prospective clinical trials. Pharmacological Reports, 58 Suppl, 16–20.

    PubMed  Google Scholar 

  38. Allessie, M. A., Boyden, P. A., Camm, A. J., Kleber, A. G., Lab, M. J., Legato, M. J., et al. (2001). Pathophysiology and prevention of atrial fibrillation. Circulation, 103(5), 769–777.

    PubMed  CAS  Google Scholar 

  39. Engelmann, M. D., & Svendsen, J. H. (2005). Inflammation in the genesis and perpetuation of atrial fibrillation. European Heart Journal, 26, 2083–2092.

    Article  PubMed  CAS  Google Scholar 

  40. Boos, C. J., Anderson, R. A., & Lip, G. Y. (2006). Is atrial fibrillation an inflammatory disorder? European Heart Journal, 27, 136–149.

    Article  PubMed  Google Scholar 

  41. Kurotobi, T., Iwakura, K., Inoue, K., Kimura, R., Okamura, A., Koyama, Y., et al. (2010). A pre-existent elevated C-reactive protein is associated with the recurrence of atrial tachyarrhythmias after catheter ablation in patients with atrial fibrillation. Europace, 12(9), 1213–1218.

    Article  PubMed  Google Scholar 

  42. Osmancik, P., Peroutka, Z., Budera, P., Herman, D., Stros, P., & Straka, Z. (2010). Changes in cytokine concentrations following successful ablation of atrial fibrillation. European Cytokine Network, 1, 21(4), 278–284.

    Google Scholar 

  43. Luan, Y., Guo, Y., Li, S., Yu, B., Zhu, S., Li, S., et al. (2010). Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease. Europace, 12(12), 1713–1718.

    Article  PubMed  Google Scholar 

  44. Degener, S., Pattberg, S. V., Feuersenger, H., Bansmann, P. M., Shin, D. I., Krummenauer, F., et al. (2007). Plasma natriuretic peptide concentrations as a predictor for successful catheter ablation in patients with drug-refractory atrial fibrillation. Circulation Journal, 71(3), 313–320.

    Article  Google Scholar 

  45. Shimano, M., Shibata, R., Inden, Y., Yoshida, N., Uchikawa, T., Tsuji, Y., et al. (2009). Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation. Heart Rhythm, 6(7), 935–940.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was fully supported by the Key Science and Technology Program of Heilongjiang Province, China (no. GC10C305-1).

Conflict of interest

None declared

Author information

Authors and Affiliations

  1. Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, No. 23 Youzheng Street, Nangang District, Harbin City, Heilongjiang Province, People’s Republic of China

    Li Yang, Qu Xiufen, Sun Shuqin, Yu Yang, Song Ying, Yu Yanwei, Feng Wei & Yin Dechun

Authors
  1. Li Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qu Xiufen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sun Shuqin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yu Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Song Ying
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yu Yanwei
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Feng Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yin Dechun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qu Xiufen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, L., Xiufen, Q., Shuqin, S. et al. Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation. J Interv Card Electrophysiol 32, 147–154 (2011). https://doi.org/10.1007/s10840-011-9588-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-011-9588-7

Keywords

Search

Navigation